Skip to content

Deep vs Moderate Block: Impact on Operating Conditions & Patient Satisfaction

Comparing Deep Neuromuscular Block and Moderate Neuromuscular Block in Patients Undergoing Laparoscopic Gynaecological Surgeries: Impact on Surgical Satisfaction of Operating Conditions and Patient Satisfaction

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02794714
Enrollment
0
Registered
2016-06-09
Start date
2016-06-30
Completion date
2017-12-31
Last updated
2018-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Blockade

Keywords

Laparoscopic Gynecologic Surgeries

Brief summary

This study compares surgeon's satisfaction of operating conditions and patient's satisfaction following laparoscopic gynecological surgeries in two groups of patients, half of whom will receive deep neuromuscular blockade and the other half, moderate neuromuscular blockade.

Detailed description

Deep neuromuscular blockade in anesthesia has been shown to improve operating conditions in retroperitoneal surgeries, while there is minimal evidence regarding this method in laparoscopic gynecological procedures.The advantage of improving surgical conditions with a deep neuromuscular blockade in laparoscopic surgery may however lead to a delayed neuromuscular recovery and hence a delay in turnover of patients. Rocuronium will be used for muscle relaxation in order to achieve the necessary depth of neuromuscular blockade. Sugammadex is a modified cyclodextrin that forms complexes with rocuronium, reducing free plasma concentrations of rocuronium and reversing its neuromuscular blocking action from any depth. The use of rocuronium will therefore aid in achieving a deep neuromuscular blockade which the investigators postulate will improve surgical conditions and the reversal with sugammadex will ensure a rapid recovery thereafter.

Interventions

Deep neuromuscular blockade attained during surgery using Rocuronium 0.6mg/kg at induction of anesthesia with intermittent boluses of 0.15 - 0.2 mg/kg to maintain a Post Tetanic Count (PTC) of 1-2 throughout surgery. Neuromuscular blockade reversed at the end of surgery with Sugammadex 4mg/kg.

Moderate neuromuscular blockade attained during surgery using Rocuronium 0.6mg/kg at induction with intermittent boluses of 0.15 - 0.2 mg/kg to maintain Train of Four Count (TOFC) of 2 throughout surgery. Neuromuscular blockade reversed at the end of surgery with Sugammadex 2mg/kg.

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Kuala Lumpur General Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

1. Patients identified from the anaesthetic clinic scheduled to undergo a laparoscopic gynaecological procedure under general anaesthesia * requiring tracheal intubation * elective surgeries (eg. laparoscopy & dye insufflation, bilateral tubal ligation, cystectomy, myomectomy, hysterectomy, salpingo-oophorectomy) 2. American Society of Anaesthesiology (ASA) I-II

Exclusion criteria

1. Anticipated difficult airway 2. Patients requiring rapid sequence induction 3. Patient anticipated to require admission to the intensive care unit (ICU) or not planned for extubation 4. Patient with liver or renal failure (creatinine clearance \<50mls/min) 5. Patients with a baseline heart rate \<50/min 6. Patients with documented or suspected neuromuscular disorder * Guillain - Barre syndrome * Cerebrovascular accidents with residual neurology * Parkinson's Disease * Myasthenia Gravis 7. Any condition making the administration of patient satisfaction questionnaire difficult/impossible • speech or hearing impairment and language barriers 8. Patients on fusidic acid or toremifene 24 hours before surgery 9. Patients on hormonal contraceptives; oral or otherwise 10. Patients on drugs, medical problems that may prolong or shorten the duration of rocuronium- (eg.. aminoglycosides, magnesium) 11. Patients with a history of allergy to rocuronium or sugammadex

Design outcomes

Primary

MeasureTime frameDescription
Deep block versus Moderate block: Impact on surgical satisfactionEvery 15 minutes from first laparoscopic view till the removal of laparoscopes at the end of surgery or up to 8 hours from 1st score.The surgeon will be required to score the quality of operating conditions every 15 minutes from 1st visualisation of peritoneal cavity until the removal of laparoscopes at the end of surgery.

Secondary

MeasureTime frameDescription
Deep block versus Moderate block: Patient satisfaction scorePost Anesthetic Recovery Score done at half hour from time of arrival at PACU and patient deemed fit for discharge up to 2 hours from time of arrival at PACUA blinded recovery nurse will administer Patient Satisfaction Questionaire
Deep block versus Moderate block: Pain scorePost Anesthetic Recovery Score done at half hour from time of arrival at PACU and patient deemed fit for discharge up to 2 hours from time of arrival at PACUA blinded recovery nurse will obtain the Pain Score using Visual Analogue Scale
Deep block versus Moderate block: PONV ScorePost Anesthetic Recovery Score done at half hour from time of arrival at PACU and patient deemed fit for discharge up to 2 hours from time of arrival at PACUA blinded recovery nurse will obtain the PONV Score using 4 point PONV scoring

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026